Related Experiment Video
Updated: Aug 26, 2025

07:16
Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
20.0K
A Canadian Provincial Screening Program for Lynch Syndrome.
James K Stone1, Remington Winter1, Deirdre Khan2
1Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
The American Journal of Gastroenterology
|October 11, 2022
Summary
Manitoba
Area of Science:
- Oncology
- Genetics
- Public Health
Background:
- Manitoba established the first Canadian provincial reflex screening program for mismatch repair immunohistochemistry (MMR-IHC) in colorectal cancer (CRC) for patients 70 years or younger in December 2017.
- This initiative aimed to improve Lynch syndrome detection through universal MMR-IHC testing.
- Evaluating program compliance and referral rates for genetic assessment is crucial for optimizing CRC management and hereditary cancer surveillance.
Purpose of the Study:
- To assess the compliance rate of universal reflex MMR-IHC screening for eligible colorectal cancer patients in Manitoba.
- To determine the referral rate of MMR-deficient cases for genetic assessment and testing.
- To identify factors influencing MMR-IHC screening and genetic referral rates in a real-world provincial program.
Main Methods:
- A retrospective analysis of colorectal adenocarcinoma specimens (March 2018–December 2020) was conducted using the provincial pathology database.
- Data were cross-referenced with the Program of Genetics and Metabolism to track referrals and genetic testing uptake for MMR-deficient cases.
- Logistic regression analysis identified predictors of MMR-IHC screening and genetic referral.
Main Results:
- Of 936 patients aged 70 or younger, 89.4% received MMR-IHC screening, with individual pathologist screening rates being a significant predictor.
- An overall referral rate of 75.8% for MMR-deficient cases was achieved, with pathologists referring 53.4% and other clinicians an additional 22.4%.
- Lynch syndrome was confirmed in 1.4% of patients via germline testing, leading to cascade testing in 8 first-degree relatives.
Conclusions:
- Manitoba's Lynch syndrome screening program demonstrates high compliance with reflex MMR-IHC testing.
- The program successfully identified Lynch syndrome cases, facilitating genetic assessment and cascade testing.
- Pathologist screening rates are key drivers for program success, highlighting the importance of standardized protocols.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.9K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.2K